{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:11:02Z","timestamp":1792188662319,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To examine preoperative use of intravitreal dexamethasone implant in patients with refractory diabetic macular edema (DME) undergoing cataract surgery. Participants in this study were 17 patients with DME refractory to previous treatment with anti-vascular endothelial growth factor agents or dexamethasone implant, and co-existent cataract. All participants received intravitreal dexamethasone implant at baseline and underwent phacoemulsification within one month after its insertion. Best-corrected visual acuity (BCVA) and central subfield thickness (CST) changes between baseline, time of cataract surgery and postoperative months 1, 2 and 3 were evaluated. At month 1 after surgery, BCVA improved significantly from 42.3\u2009\u00b1\u20099.6 to 58.7\u2009\u00b1\u200911.9 letters compared to baseline (p\u2009&lt;\u20090.001) and the improvement was sustained at month 2 and month 3 postoperatively. One month postoperatively, CST improved significantly compared to baseline (p\u2009&lt;\u20090.001) and the improvement was sustained at month 2 (p\u2009&lt;\u20090.001), while at month 3 CST started to increase, but remained significantly lower than baseline (p\u2009=\u20090.003). At month 3 postoperatively, 35.3% of patients presented recurrence of ME. Patients with refractory DME and cataract can safely undergo phacoemulsification when dexamethasone implant is inserted one month prior to surgery to ensure adequate control of postoperative inflammation and prevent deterioration of ME.<\/jats:p>","DOI":"10.1038\/s41598-020-62561-3","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:03:00Z","timestamp":1585220580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery"],"prefix":"10.1038","volume":"10","author":[{"given":"Stamatina A.","family":"Kabanarou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Xirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Boutouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Gkizis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Vasilias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Bontzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Chatziralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"62561_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"J Yau","year":"2012","unstructured":"Yau, J. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35, 556\u2013564 (2012).","journal-title":"Diabetes Care"},{"key":"62561_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0161-6420(87)33527-4","volume":"94","author":"Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema","year":"1987","unstructured":"Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 94, 761\u2013774 (1987).","journal-title":"Ophthalmology"},{"key":"62561_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0002-9394(14)71170-5","volume":"119","author":"B Klein","year":"1995","unstructured":"Klein, B. et al. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 119, 295\u2013300 (1995).","journal-title":"Am J Ophthalmol"},{"key":"62561_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/09286589509071451","volume":"2","author":"BE Klein","year":"1995","unstructured":"Klein, B. E., Klein, R., Wang, Q. & Moss, S. E. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol 2, 49\u201355 (1995).","journal-title":"Ophthalmic Epidemiol"},{"key":"62561_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.exer.2008.08.001","volume":"87","author":"AW Chan","year":"2008","unstructured":"Chan, A. W., Ho, Y. S., Chung, S. K. & Chung, S. S. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation. Exp Eye Res 87, 454\u2013461 (2008).","journal-title":"Exp Eye Res"},{"key":"62561_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/08820538.2014.959197","volume":"29","author":"NM Haddad","year":"2014","unstructured":"Haddad, N. M., Sun, J. K., Abujaber, S., Schlossman, D. K. & Silva, P. S. Cataract surgery and its complications in diabetic patients. Semin Ophthalmol 29, 329\u2013337 (2014).","journal-title":"Semin Ophthalmol"},{"key":"62561_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ophtha.2006.08.053","volume":"114","author":"SJ Kim","year":"2007","unstructured":"Kim, S. J., Equi, R. & Bressler, N. M. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114, 881\u2013889 (2007).","journal-title":"Ophthalmology"},{"key":"62561_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jamaophthalmol.2013.2313","volume":"131","author":"Diabetic Retinopathy Clinical Research Network Authors\/Writing Committee","year":"2013","unstructured":"Diabetic Retinopathy Clinical Research Network Authors\/Writing Committee. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol 131, 870\u2013879 (2013).","journal-title":"JAMA Ophthalmol"},{"key":"62561_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0161-6420(99)90148-3","volume":"106","author":"JG Dowler","year":"1999","unstructured":"Dowler, J. G., Sehmi, K. S., Hykin, P. G. & Hamilton, A. M. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 106, 663\u2013668 (1999).","journal-title":"Ophthalmology"},{"key":"62561_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/112067219900900103","volume":"9","author":"SA Sadiq","year":"1999","unstructured":"Sadiq, S. A., Sleep, T. & Amoaku, W. M. The visual results and changes in retinopathy in diabetic patients following cataract surgery. Eur J Ophthalmol 9, 14\u201320 (1999).","journal-title":"Eur J Ophthalmol"},{"key":"62561_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/bjophthalmol-2016-309838","volume":"101","author":"AK Denniston","year":"2017","unstructured":"Denniston, A. K. et al. The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema. Br J Ophthalmol 101, 1673\u20131678 (2017).","journal-title":"Br J Ophthalmol"},{"key":"62561_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","volume":"123","author":"CJ Chu","year":"2016","unstructured":"Chu, C. J. et al. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology 123, 316\u2013323 (2016).","journal-title":"Ophthalmology"},{"key":"62561_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ophtha.2009.01.014","volume":"116","author":"Y Takamura","year":"2009","unstructured":"Takamura, Y., Kubo, E. & Akagi, Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology 116, 1151\u20131157 (2009).","journal-title":"Ophthalmology"},{"key":"62561_CR14","first-page":"836","volume":"60","author":"S Wahab","year":"2010","unstructured":"Wahab, S. & Ahmed, J. Management of cataract with macular oedema due to diabetes mellitus type-II and hypertension with grid laser prior to surgery and intra-vitreal bevacizumab (Avastin) peroperatively. J Pak Med Assoc 60, 836\u2013839 (2010).","journal-title":"J Pak Med Assoc"},{"key":"62561_CR15","doi-asserted-by":"crossref","first-page":"159436","DOI":"10.1155\/2011\/159436","volume":"2011","author":"P Udaondo","year":"2011","unstructured":"Udaondo, P., Garcia-Pous, M., Garcia-Delpech, S., Salom, D. & Diaz-Llopis, M. Prophylaxis of macular edema with intravitreal ranibizumab in patients with diabetic retinopathy after cataract surgery: a pilot study. J Ophthalmol 2011, 159436 (2011).","journal-title":"J Ophthalmol"},{"key":"62561_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1089\/jop.2011.0069","volume":"28","author":"A Salehi","year":"2012","unstructured":"Salehi, A., Beni, A. N., Razmjoo, H. & Beni, Z. N. Phacoemulcification with intravitreal bevacizumab injection in patients with cataract and coexisting diabetic retinopathy: prospective randomized study. J Ocul Pharmacol Ther 28, 212\u2013218 (2012).","journal-title":"J Ocul Pharmacol Ther"},{"key":"62561_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/IAE.0b013e3182979b9e","volume":"34","author":"JB Chae","year":"2014","unstructured":"Chae, J. B. et al. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy. Retina 34, 149\u2013156 (2014).","journal-title":"Retina"},{"key":"62561_CR18","doi-asserted-by":"crossref","first-page":"7945619","DOI":"10.1155\/2016\/7945619","volume":"2016","author":"E Yumu\u015fak","year":"2016","unstructured":"Yumu\u015fak, E. & \u00d6rnek, K. Comparison of Perioperative Ranibizumab Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery. J Ophthalmol 2016, 7945619 (2016).","journal-title":"J Ophthalmol"},{"key":"62561_CR19","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/IAE.0b013e31824bebb8","volume":"32","author":"PI Rauen","year":"2012","unstructured":"Rauen, P. I. et al. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina 32, 1799\u20131803 (2012).","journal-title":"Retina"},{"key":"62561_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.sjopt.2015.10.004","volume":"30","author":"OR Ozgur","year":"2016","unstructured":"Ozgur, O. R., Ozkurt, Y., Kulekci, Z. & Evciman, T. The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edema. Saudi J Ophthalmol 30, 33\u201338 (2016).","journal-title":"Saudi J Ophthalmol"},{"key":"62561_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/ceo.12720","volume":"44","author":"LL Lim","year":"2016","unstructured":"Lim, L. L. et al. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results. Clin Exp Ophthalmol 44, 233\u2013242 (2016).","journal-title":"Clin Exp Ophthalmol"},{"key":"62561_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000489716","volume":"241","author":"T Tatsumi","year":"2019","unstructured":"Tatsumi, T. et al. Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema. Ophthalmologica 241, 17\u201323 (2019).","journal-title":"Ophthalmologica"},{"key":"62561_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1167\/iovs.10-5285","volume":"52","author":"JE Chang-Lin","year":"2011","unstructured":"Chang-Lin, J. E. et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52, 80\u201386 (2011).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"62561_CR24","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer, D. S. et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121, 1904\u20131914 (2014).","journal-title":"Ophthalmology"},{"key":"62561_CR25","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","volume":"118","author":"JA Haller","year":"2011","unstructured":"Haller, J. A. et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118, 2453\u20132460 (2011).","journal-title":"Ophthalmology"},{"key":"62561_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","volume":"129","author":"C Lowder","year":"2011","unstructured":"Lowder, C. et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129, 545\u2013553 (2011).","journal-title":"Arch Ophthalmol"},{"key":"62561_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5301\/ejo.5000375","volume":"24","author":"C Furino","year":"2014","unstructured":"Furino, C., Boscia, F., Recchimurzo, N., Sborgia, C. & Alessio, G. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification. Eur J Ophthalmol 24, 387\u2013391 (2014).","journal-title":"Eur J Ophthalmol"},{"key":"62561_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5301\/ejo.5000523","volume":"25","author":"AM Sze","year":"2015","unstructured":"Sze, A. M., Luk, F. O., Yip, T. P., Lee, G. K. & Chan, C. K. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification. Eur J Ophthalmol 25, 168\u2013172 (2015).","journal-title":"Eur J Ophthalmol"},{"key":"62561_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5301\/ejo.5000920","volume":"27","author":"GA Panozzo","year":"2016","unstructured":"Panozzo, G. A., Gusson, E., Panozzo, G. & Dalla Mura, G. Dexamethasone intravitreal implant at the time of cataract surgery in eyes with diabetic macular edema. Eur J Ophthalmol 27, 433\u2013437 (2016).","journal-title":"Eur J Ophthalmol"},{"key":"62561_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/IAE.0000000000001552","volume":"38","author":"P Calvo","year":"2018","unstructured":"Calvo, P., Ferreras, A., Al Adel, F., Dangboon, W. & Brent, M. H. Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery. Retina 38, 490\u2013496 (2018).","journal-title":"Retina"},{"key":"62561_CR31","doi-asserted-by":"crossref","first-page":"4896036","DOI":"10.1155\/2017\/4896036","volume":"2017","author":"C Furino","year":"2017","unstructured":"Furino, C. et al. Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex\u00ae) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema. J Ophthalmol 2017, 4896036 (2017).","journal-title":"J Ophthalmol"},{"key":"62561_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/IAE.0000000000001234","volume":"37","author":"A Malcl\u00e8s","year":"2017","unstructured":"Malcl\u00e8s, A. et al. Real-life study in diabetic macular edema treated with dexamethasone implant: The Reldex Study. Retina 37, 753\u2013760 (2017).","journal-title":"Retina"},{"key":"62561_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0779-1","volume":"18","author":"Y He","year":"2018","unstructured":"He, Y., Ren, X. J., Hu, B. J., Lam, W. C. & Li, X. R. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. BMC Ophthalmol 18, 121 (2018).","journal-title":"BMC Ophthalmol"},{"key":"62561_CR34","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2147\/DDDT.S138922","volume":"11","author":"V Bonfiglio","year":"2017","unstructured":"Bonfiglio, V. et al. Widening use of dexamethasone implant for the treatment of macular edema. Drug Des Devel Ther 11, 2359\u20132372 (2017).","journal-title":"Drug Des Devel Ther"},{"key":"62561_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ophtha.2012.08.002","volume":"120","author":"A Agarwal","year":"2013","unstructured":"Agarwal, A., Gupta, V., Ram, J. & Gupta, A. Dexamethasone intravitreal implant during phacoemulsification. Ophthalmology 120, 211 (2013).","journal-title":"Ophthalmology"},{"key":"62561_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3928\/23258160-20150101-09","volume":"46","author":"RN Khurana","year":"2015","unstructured":"Khurana, R. N., Palmer, J. D., Porco, T. C. & Wieland, M. R. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes. Ophthalmic Surg Lasers Imaging Retina 46, 56\u201361 (2015).","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"62561_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","volume":"76","author":"JD Gass","year":"1966","unstructured":"Gass, J. D. & Norton, E. W. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76, 646\u2013661 (1966).","journal-title":"Arch Ophthalmol"},{"key":"62561_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0161-6420(99)90004-0","volume":"106","author":"JC Norregaard","year":"1999","unstructured":"Norregaard, J. C. et al. Intraoperative clinical practice and risk of early complications after cataract extraction in the United States, Canada, Denmark, and Spain. Ophthalmology 106, 42\u201348 (1999).","journal-title":"Ophthalmology"},{"key":"62561_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajo.2015.10.005","volume":"161","author":"SJ Kim","year":"2016","unstructured":"Kim, S. J. & Jampel, H. Prevention of Cystoid Macular Edema After Cataract Surgery in Non-Diabetic and Diabetic Patients: A Systematic Review and Meta-Analysis. Am J Ophthalmol 161, 221\u2013222 (2016).","journal-title":"Am J Ophthalmol"},{"key":"62561_CR40","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s13300-017-0332-x","volume":"8","author":"I Chatziralli","year":"2017","unstructured":"Chatziralli, I. et al. Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome. Diabetes Ther 8, 1393\u20131404 (2017).","journal-title":"Diabetes Ther"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62561-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:37:55Z","timestamp":1670315875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62561-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62561"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62561-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5534"}}